Insider Transactions in Q4 2023 at Pulmonx Corp (LUNG)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2023
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.48%
|
$14,208
$12.75 P/Share
|
Dec 21
2023
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
10,000
-0.86%
|
$120,000
$12.42 P/Share
|
Dec 01
2023
|
John Mc Kune INTERIM CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,233
+13.18%
|
-
|
Dec 01
2023
|
John Mc Kune INTERIM CFO |
SELL
Open market or private sale
|
Direct |
942
-0.76%
|
$9,420
$10.34 P/Share
|
Dec 01
2023
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,868
-0.38%
|
$28,680
$10.34 P/Share
|
Dec 01
2023
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
6,676
-0.19%
|
$66,760
$10.34 P/Share
|
Dec 01
2023
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,809
-0.83%
|
$38,090
$10.34 P/Share
|
Nov 22
2023
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.47%
|
$11,840
$10.6 P/Share
|
Oct 23
2023
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.47%
|
$9,472
$8.35 P/Share
|